Biotricity, News

Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022

Biotricity Inc. (Biotricity) will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022.  The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since late-February 2022.

Recent Comments

لا توجد تعليقات للعرض.
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
موقع YouTube
Consent to display content from - Youtube
فيميو
Consent to display content from - Vimeo
خرائط جوجل
Consent to display content from - Google
سبوتيفي
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound